CID 138453970

Bishomopalytoxin

Structural Information

Molecular Formula
C131H227N3O54
SMILES
C[C@H]1C[C@@]2([C@H](O[C@](C1)(O2)CCCCCCC[C@@H](C[C@@H]3[C@@H]([C@H]([C@H]([C@@](O3)(C[C@@H]([C@@H](C)/C=C/[C@H](CC[C@H]([C@H]([C@@H]4C[C@H]([C@@H]([C@H](O4)C[C@H]([C@@H](C[C@@H]5[C@H]([C@@H]([C@H]([C@@H](O5)C[C@@H](/C=C\C=C\C[C@H]([C@@H]([C@@H](C/C=C\C(=C)CC[C@@H]([C@H]([C@@H]([C@H](C)C[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)/C=C\[C@H]([C@@H](C[C@@H]7C[C@@H]8C[C@H](O7)[C@H](O8)CC[C@@H]9[C@@H](C[C@H](O9)CN)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)C[C@@H](C)CCCCC[C@H]([C@@H]([C@@H]([C@H]([C@@H]([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)C[C@@H]([C@@H](/C(=C/[C@@H](C[C@@H](C)[C@@H](C(=O)N/C=C/C(=O)NCCCCCO)O)O)/C)O)O)O)O)O)O)O)O)O)O)C
InChI
InChI=1S/C131H227N3O54/c1-64(31-35-83(145)110(160)105(155)70(7)49-95-113(163)119(169)112(162)93(182-95)38-37-78(140)84(146)53-75-52-76-55-94(180-75)92(179-76)40-39-91-87(149)54-77(63-132)181-91)25-23-30-80(142)107(157)79(141)28-19-13-17-27-72(137)50-96-114(164)120(170)115(165)99(183-96)57-86(148)85(147)56-97-109(159)89(151)59-98(184-97)108(158)82(144)36-34-71(136)33-32-67(4)90(152)62-131(178)127(176)125(175)117(167)101(186-131)51-73(138)26-16-10-9-11-20-42-130-61-66(3)60-129(8,188-130)102(187-130)46-65(2)24-15-12-18-29-81(143)111(161)118(168)122(172)124(174)126-123(173)121(171)116(166)100(185-126)58-88(150)104(154)68(5)47-74(139)48-69(6)106(156)128(177)134-44-41-103(153)133-43-21-14-22-45-135/h13,17,19,23,25,27,32-33,37-38,41,44,47,65-67,69-102,104-127,135-152,154-176,178H,1,9-12,14-16,18,20-22,24,26,28-31,34-36,39-40,42-43,45-46,48-63,132H2,2-8H3,(H,133,153)(H,134,177)/b19-13+,25-23-,27-17-,33-32+,38-37-,44-41+,68-47+/t65-,66-,67-,69+,70+,71+,72+,73-,74-,75-,76+,77-,78+,79+,80+,81+,82+,83-,84+,85+,86+,87+,88-,89+,90-,91+,92+,93+,94-,95+,96-,97+,98-,99+,100+,101+,102+,104+,105+,106-,107-,108+,109-,110+,111-,112+,113-,114-,115+,116-,117-,118-,119-,120+,121+,122+,123-,124-,125+,126-,127+,129+,130-,131-/m0/s1
InChIKey
LJQIHGIMMFWMEN-VXCGPZBCSA-N
Compound name
(E,2S,3R,5R,8R,9S)-10-[(2R,3R,4R,5S,6R)-6-[(1S,2R,3S,4S,5R,11S)-12-[(1R,3S,5S,7R)-5-[(8S)-9-[(2R,3R,4R,5R,6S)-6-[(E,2S,3S,6S,9R,10R)-10-[(2S,4R,5S,6R)-6-[(2R,3R)-4-[(2R,3S,4R,5R,6S)-6-[(2S,3Z,5E,8R,9S,10R,12Z,17S,18R,19R,20R)-21-[(2R,3R,4R,5S,6R)-6-[(Z,3R,4R)-5-[(1S,3R,5R,7R)-7-[2-[(2R,3R,5S)-5-(aminomethyl)-3-hydroxyoxolan-2-yl]ethyl]-2,6-dioxabicyclo[3.2.1]octan-3-yl]-3,4-dihydroxypent-1-enyl]-3,4,5-trihydroxyoxan-2-yl]-2,8,9,10,17,18,19-heptahydroxy-20-methyl-14-methylidenehenicosa-3,5,12-trienyl]-3,4,5-trihydroxyoxan-2-yl]-2,3-dihydroxybutyl]-4,5-dihydroxyoxan-2-yl]-2,6,9,10-tetrahydroxy-3-methyldec-4-enyl]-3,4,5,6-tetrahydroxyoxan-2-yl]-8-hydroxynonyl]-1,3-dimethyl-6,8-dioxabicyclo[3.2.1]octan-7-yl]-1,2,3,4,5-pentahydroxy-11-methyldodecyl]-3,4,5-trihydroxyoxan-2-yl]-2,5,8,9-tetrahydroxy-N-[(E)-3-(5-hydroxypentylamino)-3-oxoprop-1-enyl]-3,7-dimethyldec-6-enamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

2706.511 Da
Monoisotopic Mass

-5.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2707.5183 481.4
[M+Na]+ 2729.5002 475.0
[M-H]- 2705.5037 497.7
[M+NH4]+ 2724.5448 479.0
[M+K]+ 2745.4742 474.3
[M+H-H2O]+ 2689.5083 462.0
[M+HCOO]- 2751.5092 474.0
[M+CH3COO]- 2765.5249 470.2
[M+Na-2H]- 2727.4857 496.9
[M]+ 2706.5105 445.0
[M]- 2706.5115 445.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.